Citrate Assay Kits

Assay Principle

Citrate (citric acid) is a central intermediate of the tricarboxylic acid cycle, and its concentration in blood, urine, and tissue is influenced by diet, age, sex hormones, parathyroid hormone, and overall metabolic state. A citrate assay commonly relies on a chromium-based redox reaction chemistry: under acidic conditions, hexavalent chromium is reduced to trivalent chromium, and the resulting Cr(III) reacts with citric acid to form a complex with a characteristic absorption peak, typically read around 545 nm, that is proportional to citrate concentration. This approach allows direct quantification from a small sample volume on a standard microplate reader without requiring an enzymatic coupling step, which distinguishes it from some other TCA cycle intermediate assays that rely on NAD(P)H-linked dehydrogenase chemistry.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are validated for serum, plasma, animal tissue homogenates, and isolated mitochondria, reflecting citrate's relevance at both the systemic (blood, urine) and organelle levels of metabolic research. Reported sensitivity for this chemistry is typically in the range of 0.06 to 2 mmol/L, a range well suited to the relatively high physiological citrate concentrations found in plasma and tissue extracts compared to many other small-molecule metabolite assays. Because citrate levels are sensitive to recent dietary intake and time of sample collection, standardizing collection conditions across a study is a reasonable precaution regardless of which kit is used.

Assay Kit Purchasing Considerations

Because the chromium-based colorimetric chemistry used to quantify citrate is common across several suppliers, the more consequential comparison points are validated sample compatibility (particularly whether isolated mitochondria are supported, which matters for organelle-level metabolic flux studies) and whether the kit's detection range comfortably spans both the lower citrate concentrations typical of certain disease states and the higher concentrations found in healthy tissue. For urinary citrate applications relevant to kidney stone research, confirming that a kit has been validated specifically in urine, rather than only in serum or plasma, is worth checking given urine's distinct matrix composition. As with other TCA cycle intermediate assays, a well-characterized citrate standard curve is the most reliable way to verify assay performance before running experimental samples. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.